2-Mercaptoethanesulfonic Acid: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for 2-Mercaptoethanesulfonic Acid. Educational only — not medical advice.
Labeled uses
Mesna Injection is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Limitation of Use: Mesna Injection is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia.
Source: FDA labeling via NIH DailyMed (set ef161ede…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.